Trevi Therapeutics to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 5, 2026

Go back to Trevi Therapeutics to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 5, 2026
(NASDAQ: TRVI) Delayed: 17.71 +0.50 (2.91%)
Previous Close $17.21    52 Week High
Open $17.41    52 Week Low
Day High $18.11    P/E N/A 
Day Low $17.16    EPS
Volume 2,460,936